Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome

NCT00241215 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Cervicobrachial Neuralgia
Myofascial Pain Syndromes

Interventions

DRUG: Botulinum toxin serotype A

Sponsor

University of California, Los Angeles

Collaborators

[object Object]